List of works - Roy Blum

A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.

scientific article

Activation of muscle enhancers by MyoD and epigenetic modifiers.

scientific article published in November 2014

Comment on "Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing".

scientific article published on June 2017

Denaturing CLIP, dCLIP, Pipeline Identifies Discrete RNA Footprints on Chromatin-Associated Proteins and Reveals that CBX7 Targets 3' UTRs to Regulate mRNA Expression

scientific article published in October 2017

Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).

scientific article published on April 2007

Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1.

scientific article published on December 2012

Genome-wide remodeling of the epigenetic landscape during myogenic differentiation.

scientific article

Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance

scientific article published on 29 June 2014

Inhibitors of chronically active ras: potential for treatment of human malignancies.

scientific article published on January 2008

Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

scientific article

Metabolism addiction in pancreatic cancer

scientific article published on 20 February 2014

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer

scientific article

Motif-driven interactions between RNA and PRC2 are rheostats that regulate transcription elongation

scientific article published on 04 January 2021

Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.

scientific article

Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death

scientific article

Stepping inside the realm of epigenetic modifiers.

scientific article published on April 2015

Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis

scientific article published on September 2006

Tailoring Ras-pathway--inhibitor combinations for cancer therapy.

scientific article

The role of MyoD1 and histone modifications in the activation of muscle enhancers.

scientific article published on 27 June 2013

Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function

article published in the Proceedings of the National Academy of Sciences of the United States of America

Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosome

scientific article published on 21 January 2019

List of works by Roy Blum

A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.

Activation of muscle enhancers by MyoD and epigenetic modifiers.

Comment on "Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing".

Denaturing CLIP, dCLIP, Pipeline Identifies Discrete RNA Footprints on Chromatin-Associated Proteins and Reveals that CBX7 Targets 3' UTRs to Regulate mRNA Expression

Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).

Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1.

Genome-wide remodeling of the epigenetic landscape during myogenic differentiation.

Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance

Inhibitors of chronically active ras: potential for treatment of human malignancies.

Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

Metabolism addiction in pancreatic cancer

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer

Motif-driven interactions between RNA and PRC2 are rheostats that regulate transcription elongation

Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.

Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death

Stepping inside the realm of epigenetic modifiers.

Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis

Tailoring Ras-pathway--inhibitor combinations for cancer therapy.

The role of MyoD1 and histone modifications in the activation of muscle enhancers.

Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function

Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosome